SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-16-003809
Filing Date
2016-11-15
Accepted
2016-11-15 17:08:44
Documents
5
Period of Report
2016-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k111516_8k.htm 8-K 11995
2 EXHIBIT 99.1 PRESS RELEASE f8k111516_ex99z1.htm EX-99.1 15353
3 EXHIBIT 99.2 TRANSCRIPT OF CONFERENCE CALL f8k111516_ex99z2.htm EX-99.2 68564
4 IMAGE f8k111516_ex99z2002.jpg GRAPHIC 850912
5 IMAGE f8k111516_ex99z2001.jpg GRAPHIC 91749
  Complete submission text file 0001078782-16-003809.txt   1394553
Mailing Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208
Business Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 162000483
SIC: 2835 In Vitro & In Vivo Diagnostic Substances